Rectification of mistake remains limited to self-evident record errors, preventing merits review through miscellaneous applications and preserving fin...
Tender creditworthiness conditions may extend to de facto Promoter Directors, with post-participation challenges generally barred absent arbitrariness...
Corporate representation in PMLA summons proceedings permitted through an authorised signatory, subject to directors' continuing cooperation and atten...
Helicopter charter classification requires effective control analysis, while territorial performance, reasoned credit orders and wilful suppression de...
Seven new Standard Input Output Norms under the Chemical and Allied Products group prescribe permitted import inputs and quantities for specified export products, including theophylline, liraglutide injection, lumefantrine, meropenem formulations and ophthalmic solutions. The norms specify relevant bulk drugs, chemicals and sterile bulk materials as allowable inputs; for ophthalmic solutions, bulk-drug content must conform to the Drug Manufacturing Licence. The new entries enable Regional Authorities to issue Advance Authorisations directly in eligible cases without individual referral to the Norms Committee, promoting faster processing and uniform norm fixation.
Seven new Standard Input Output Norms under the Chemical and Allied Products group prescribe permitted import inputs and quantities for specified export products, including theophylline, liraglutide injection, lumefantrine, meropenem formulations and ophthalmic solutions. The norms specify relevant bulk drugs, chemicals and sterile bulk materials as allowable inputs; for ophthalmic solutions, bulk-drug content must conform to the Drug Manufacturing Licence. The new entries enable Regional Authorities to issue Advance Authorisations directly in eligible cases without individual referral to the Norms Committee, promoting faster processing and uniform norm fixation.
Note: It is a system-generated summary and is for quick reference only.